Tacit Therapeutics

About:

Tacit Therapeutics created RNA-targeting treatments for devastating diseases.

Top Investors: National Science Foundation, Eisai Innovation

Description:

Tacit Therapeutics created RNA-targeting treatments for devastating diseases. By repurposing pre-existing components of human cells, we have created the first broadly applicable and inherently non-immunogenic means to repair mutated genes. The company was founded in 2021 and is based in South San Francisco, California.

Total Funding Amount:

$9.75M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2021-01-01

Founders:

David Nelles

Number of Employees:

1-10

Last Funding Date:

2022-06-08

IPO Status:

Private

Industries: